What is the market valuation of brain PET-MRI systems?

The market size of brain PET-MRI systems in 2027 is calculated to be USD 418.02 million.

What is the projected value of the brain PET-MRI systems industry by 2036?

Brain PET-MRI Systems Market size was valued at USD 398.87 million in 2026 and is projected to grow at a 5.7% CAGR from 2027 to 2036, attaining USD 694.35 million by 2036.

How is the adoption of hybrid PET-MRI systems reshaping clinical workflow and procurement strategies in neurology centers?

It is driving preference for integrated hybrid systems that enable single-session imaging and reduce reliance on separate workflows. Procurement is increasingly focused on improving diagnostic efficiency, minimizing image misregistration, and strengthening cross-specialty collaboration.

What is driving increased demand for ultra-high-resolution and multiparametric brain imaging in clinical and research settings?

Demand is rising due to the need for more precise visualization of subtle neurological abnormalities. Combined metabolic and structural insights support earlier detection and improve diagnostic confidence in complex conditions like neurodegeneration and brain oncology.

Why does the Pre-clinical phase dominate the brain PET-MRI systems market?

Pre-clinical leads with 60.9% due to strong use in neuroscience research, translational studies, and established experimental imaging workflows requiring integrated PET-MRI for controlled studies and long development cycles.

What is driving growth in Helium-free PET-MRI systems?

Helium-free PET-MRI systems are fastest-growing due to reduced reliance on helium cooling, lower operational constraints, improved sustainability, and easier long-term maintenance, supporting broader adoption in clinical and research facilities.

Why does North America lead the brain PET-MRI systems market?

North America held a 32.22% market share in 2026, supported by advanced diagnostic imaging infrastructure, widespread use of multimodal neuroimaging, and strong deployment across hospitals, research centers, and specialized imaging facilities.

What is driving growth in the brain PET-MRI systems market across Asia Pacific?

Asia Pacific is projected to grow at a 6.89% CAGR as healthcare providers expand advanced imaging capacity, invest in modern diagnostic equipment, and improve access to specialized neurological evaluation.

Which companies dominate the brain PET-MRI systems landscape?

Major players in the brain PET-MRI systems market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Mediso Ltd. (Hungary), MR Solutions Ltd. (United Kingdom), Cubresa Inc. (Canada), United Imaging Healthcare Co., Ltd. (China).